Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Leases (2022 - 2025)

Rapid Micro Biosystems' Current Leases history spans 4 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Current Leases changed N/A year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, changed N/A, while the annual FY2024 figure was $1.2 million, 7.24% up from the prior year.
  • Current Leases for Q3 2025 was $1.3 million at Rapid Micro Biosystems, up from $1.2 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.3 million in Q3 2025 and bottomed at $635000.0 in Q1 2022.
  • The 4-year median for Current Leases is $1.1 million (2023), against an average of $1.0 million.
  • The largest YoY upside for Current Leases was 7.24% in 2024 against a maximum downside of 7.24% in 2024.
  • A 4-year view of Current Leases shows it stood at $635000.0 in 2022, then surged by 78.27% to $1.1 million in 2023, then grew by 7.24% to $1.2 million in 2024, then rose by 5.19% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Current Leases are $1.3 million (Q3 2025), $1.2 million (Q4 2024), and $1.1 million (Q4 2023).